Companies: 10,795·Total market cap: $144.5T
Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc.

DBTXNASDAQHealthcare
$4.91
$-0.04(-0.81%)
Market Cap$123373079
P/E Ratio—
52W High$5.4
52W Low$1.61
SEC Filings

Decibel Therapeutics, Inc. (DBTX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001656536 · DBTX · NASDAQ · as of Jun 8, 2026

Filing snapshot

177
Total Filings
SC 13G/A
Latest Form
2024-02-14
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001656536 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-14
Fiscal Year End
Mar 14, 2023
Accession No.
0000950170-23-007849
Primary Document
dbtx-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001656536 · Accession 0000950170-23-007849

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-11
View 10-Q on SEC
8-KCurrent Report
8-K
2023-09-25Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-02-14
View
15-12G15-12G
15-12G
2023-10-10
View
EFFECTEFFECT
EFFECT
2023-10-06
View
SC 13D/ASC 13D/A
SC 13D/A
2023-09-27
View
S-8 POSS-8 POS
S-8 POS
2023-09-25
View
S-8 POSS-8 POS
S-8 POS
2023-09-25
View
S-8 POSS-8 POS
S-8 POS
2023-09-25
View
POS AMPOS AM
POS AM
2023-09-25
View
8-KCurrent Report
8-K
2023-09-25
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-09-25
View
25-NSE25-NSE
25-NSE
2023-09-25
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2023-09-25
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2023-09-12
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-09-12
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-09-08
View
Showing 1–15 of 125 filingsForm 4 / 144 hidden· 177 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001656536  |  Exchange: NASDAQ · Healthcare

Decibel Therapeutics, Inc. (NASDAQ: DBTX) has submitted 177 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001656536, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Decibel Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Decibel Therapeutics, Inc. 10-K was filed on 2023-03-14 for fiscal year ending 2023. Historical DBTX 10-K annual reports are available from 2015 through 2023.

Investors researching Decibel Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TRML SEC Filings →SELB SEC Filings →PRDS SEC Filings →NGM SEC Filings →SESN SEC Filings →PRTK SEC Filings →KNTE SEC Filings →GRAY SEC Filings →
→ DBTX Financials→ DBTX Earnings→ DBTX Insider Trades

Frequently Asked Questions

DBTX SEC Filings · 8 questions

Decibel Therapeutics, Inc. (DBTX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 177 filings and access original documents at no cost. Decibel Therapeutics, Inc.'s CIK is 0001656536.

DBTX SEC filingsDecibel Therapeutics, Inc. SEC documentsfind DBTX 10-K